Advocacy Campaign Video
A New Era in Cancer Treatment
Brand Storytelling | Interviews | Healthcare Advocacy
The need.
The Canadian Association of Nuclear Medicine (CANM) needed to raise awareness and drive action around Radioligand Therapy (RLT)—a Health Canada–approved cancer treatment still inaccessible in key provinces, particularly Quebec. The challenge was both educational and systemic: policymakers, healthcare leaders, and the public needed to understand its clinical value and the human cost of delayed access. The message had to resonate with patients, physicians, and decision-makers alike, balancing scientific credibility with emotional impact.
The solution.
We produced two campaign films—one in English and one in French—to inform, humanize, and advocate. Combining patient stories with expert interviews, the videos translated complex medical information into clear, compelling narratives. Cinematic b-roll of treatment settings and real patient experiences grounded the message, while purposeful storytelling emphasized the urgency of access and reimbursement—making the case for change both clear and difficult to ignore.
A national conversation.
Filmed with leading physicians and a Canadian patient, the production reflected both the clinical authority and human impact of RLT. The bilingual approach ensured accessibility and relevance across provinces, particularly in regions where adoption decisions were still pending.
Human stories.
Clinical truth.
The narrative was built around real patient experiences alongside expert medical insight, creating a powerful intersection between data and lived reality. The result was a message that felt both credible to professionals and deeply relatable to the public.
The Message
A New Era in Cancer Treatment
Radioligand Therapy represents a major advancement in targeted cancer care—improving survival outcomes and quality of life while highlighting the urgent need for equitable access across Canada.
Science made human.
By combining physician expertise with the patient journey, the films bridged the gap between complex treatment science and public understanding—making innovation feel tangible, immediate, and necessary.
Results delivered.
Two bilingual advocacy films, interview-driven storytelling, and strategic messaging designed to influence public perception and policy. The campaign contributed to the successful adoption of Radioligand Therapy being covered in Quebec and broader awareness across provinces nationwide.
